UMC Governing Board Audit & Finance Committee
Summary
EBITDA loss of $500K, negative margins, labor costs above budget.
What Matters to Employees 10 items
EBITDA $4.8M above budget; liquidity red, 44.8 days cash.
$84M reduction starting 2028; 100K Nevadans may lose Medicaid.
All goals met; 100% award recommended.
Six goals proposed; goal #4 revenue capture $7.5M debated.
3-year extension with updated fee schedule.
New agreement for kidney/pancreas transplants.
Extension while negotiating new terms.
Extension while negotiating new terms.
5-year agreement for 24/7 stroke neurology.
2-year extension, increased funding.
All Agenda Items 9 items
EBITDA loss $500K vs budget $1.7M; net revenue below $3.4M.
Project completed on time, under budget with $2.3M savings.
Goals include EBITDA, ALOS, labor utilization, revenue capture.
Rate increase and extension through July 2027.
Rate increase and extension through July 2027.
New 3-year agreement with independent PPO network.
2-year commitment for reagents; HPG pricing.
New 5-year agreement for transplant waiting list access.
Upgrade from 20-year-old unsupported system.
Related Historical Findings
Hospital sets labor cost goal below budget, squeezing staff wages.
SWB per APD target set below budget, cutting $3M or $5.8M in labor costs.
"Goal #3 on labor utilization offers two options. The financial EBITDA impact for SWB per APD for proposal 1 is .5% below budget, equating to $3 million, while for proposal 2, it is 1% below budget, corresponding to a $5.8 million impact."